VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MHLA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MHLAMaiden Holdings, Ltd. 6.625 NT 2046
$10.85$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMHLAQuarterly Financials

Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Maiden Holdings, Ltd. 6.625 NT 2046 (MHLA) quarterly income statement — complete revenue, gross profit & net income history

MHLA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20
Revenue14.05M-7.43M14.48M20.49M28.9M25.21M21.75M22.78M19.49M9.71M17.68M20.69M10.05M25.06M21.71M21.98M29.98M39.69M40.58M44.74M
Revenue Growth %-51.39%-129.49%-33.45%-10.07%48.28%159.61%23.02%10.1%93.98%-61.26%-18.54%-5.86%-66.48%-36.85%-46.5%-50.88%-49.3%-34.01%-66.52%-76.45%
Medical Costs & Claims00000000000000000000
Medical Cost Ratio %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Gross Profit14.05M-7.43M14.48M20.49M28.9M25.21M21.75M22.78M19.49M9.71M17.68M20.69M10.05M25.06M21.71M21.98M29.98M39.69M40.58M44.74M
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-51.39%-129.49%-33.45%-10.07%48.28%159.61%23.02%10.1%93.98%-61.26%-18.54%-5.86%-66.48%-36.85%-46.5%-50.88%-49.3%-34.01%-66.52%-76.45%
Operating Expenses10.77M-5.16M10.01M7.88M8.06M-37.86M20.5M21.13M27.02M56.88M21.1M12.18M5.91M7.46M20.17M9.29M15.81M25.45M33.57M30.72M
OpEx / Revenue %76.68%69.48%69.17%38.46%27.89%-150.21%94.23%92.77%138.64%585.83%119.33%58.86%58.82%29.78%92.92%42.27%52.74%64.12%82.72%68.66%
Depreciation & Amortization08.69M0-9.53M843K454K5.53M536K4.67M38.24M11.63M-1.64M35K223K705K1.55M970K-16.88M-13.7M-16.32M
Combined Ratio %76.68%69.48%69.17%38.46%27.89%-150.21%94.23%92.77%138.64%585.83%119.33%58.86%58.82%29.78%92.92%42.27%52.74%64.12%82.72%68.66%
Operating Income3.28M-16.83M4.46M12.61M3.63M18.14M-5.53M-536K-4.67M-38.24M-11.63M1.64M-1.08M13.15M-1.77M11.5M7.68M16.88M13.7M16.32M
Operating Margin %23.32%226.41%30.83%61.54%12.54%71.98%-25.41%-2.35%-23.93%-393.87%-65.77%7.91%-10.77%52.46%-8.15%52.33%25.61%42.53%33.77%36.47%
Operating Income Growth %-9.65%-192.74%180.73%2452.24%177.73%147.45%52.47%-132.74%-331.15%-390.89%-557.49%-85.77%-114.09%-22.12%-112.91%-29.53%-56.16%448.47%122.35%148.27%
EBITDA-3.81M-8.14M4.46M3.08M4.47M18.6M000000-1.05M13.37M-1.06M13.05M8.65M000
EBITDA Margin %-27.15%109.54%30.83%15.03%15.46%73.78%0%0%0%0%0%0%-10.42%53.35%-4.9%59.4%28.85%0%0%0%
Interest Expense4.82M4.82M4.82M4.82M4.82M4.82M4.81M03.82M04.83M4.83M4.83M04.83M4.83M4.83M04.83M4.83M
Non-Operating Income-10.23M201.1M34.09M-12.61M-20.84M-18.14M-14.97M-15.94M-9.38M-3.43M-11.19M-1.64M837K-18.59M-15.06M-13.07M-15.98M-26.54M-32.42M-35.48M
Pretax Income-8.63M-157.41M-34.44M-9.53M1.47M-20.33M-3.56M-3.13M-11.36M-52M-8.25M3.39M-694K12.77M-3.29M7.86M9.34M9.41M2.18M9.19M
Pretax Margin %-61.45%2118.03%-237.92%-46.51%5.09%-80.66%-16.35%-13.73%-58.26%-535.61%-46.66%16.38%-6.91%50.94%-15.18%35.74%31.14%23.71%5.37%20.55%
Income Tax12K577K25K442K11K449K-31K-194K-28K-1.01M-91K-713K1.25M378K-155K-257K49K-118K17K-18K
Effective Tax Rate %-0.14%-0.37%-0.07%-4.64%0.75%-2.21%0.87%6.2%0.25%1.94%1.1%-21.03%-180.84%2.96%4.7%-3.27%0.52%-1.25%0.78%-0.2%
Net Income-8.64M-157.97M-34.47M-9.97M1.44M-20.78M-3.53M-2.93M-11.33M36.04M-8.16M925K1.58M16.21M2.85M26.63M70.6M46.9M2.14M9.04M
Net Margin %-61.53%2125.57%-238.09%-48.67%4.99%-82.44%-16.21%-12.88%-58.11%371.21%-46.14%4.47%15.76%64.7%13.11%121.16%235.54%118.17%5.27%20.21%
Net Income Growth %-699.51%-660.18%-877.26%-239.96%112.73%-157.66%56.78%-417.08%-815.15%122.3%-386.62%-96.53%-97.76%-65.43%33.16%194.43%242.5%322.95%103.66%127.46%
EPS (Diluted)-0.090.43-0.35-0.100.01-0.21-0.03-0.03-0.110.41-0.090.010.020.190.030.310.830.550.030.11
EPS Growth %-725%304.76%-905.75%-245.83%113.09%-151.22%62.82%-371.7%-701.09%115.79%-384.5%-96.58%-97.8%-65.45%30.56%181.82%232%320%103.6%129.65%
EPS (Basic)-0.090.43-0.35-0.100.01-0.21-0.03-0.03-0.110.41-0.090.010.020.180.030.310.830.550.030.11
Diluted Shares Outstanding99.12M99.9M99.72M100.16M100.46M100.78M101.45M101.75M101.55M87.64M87.16M87.09M86.55M86.47M86.44M86.24M85.14M84.79M84.74M84.54M